Imagine using a specially treated piece of rattan wood that acts like a biological scaffold. It tricks the body into thinking it's real bone, encouraging new bone to grow right into its pores. This helps heal serious spinal gaps much faster and more reliably than current options.
Current bone grafts often fail due to lack of vascularization, leading to a 25% non-union rate and high risks of infection or amputation. This creates massive economic burdens on healthcare systems and patients.
The b.Spine biomimetic bone graft and b.Putty moldable variant, both derived from a proprietary rattan wood transformation process.
If you are a spinal implant manufacturer dealing with high non-union rates in spinal fusion—this project developed b.Spine, a biomimetic graft that achieved a 100% fusion success rate at 12 months. This allows for safer surgeries and better patient outcomes.
If you are a synthetic bone graft developer dealing with materials that lack vascularization—this project developed a proprietary biomorphic transformation process for rattan wood. This creates a 3D pore structure that mimics human bone to drive de-novo mineralization.
If you are a clinic network dealing with the high social costs of bone defect failures—this project developed b.Putty, a moldable bone substitute. This provides a versatile tool for treating complex bone defects with superior in vitro performance.
Based on available project data, specific pricing or cost per unit is not mentioned.
The project successfully completed process validation and is aiming for a 10% market share by 2030, suggesting a plan for industrial scaling.
The project utilizes a proprietary biomaterial platform and has specifically patented the b.Putty moldable variant.
The project has achieved CE mark readiness through rigorous preclinical and clinical testing.
The objective is to bring the product to the spinal market segment in 2025.
The project is led by a single Italian SME, GreenBone Ortho SPA, representing a 100% industry ratio. This lean structure indicates a highly focused commercial drive, moving directly from proprietary R&D to clinical validation and CE certification without the overhead of academic partners.
Contact GreenBone Ortho SPA in Italy regarding b.Spine and b.Putty licensing.
Contact us to explore partnership opportunities with this CE-ready biomaterial leader.
